David Preiss
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
-
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Treatment and Management 27
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Diabetes Management and Research 9
- Co-authors
- Naveed SattarJohn J.V. McMurraySøren Lund KristensenPardeep S. JhundMark C. PetrieLars KøberKausik K. RayRasmus Rørth
- Journals
- The Lancet Diabetes & Endocrinology (16 papers)Diabetologia (7 papers)Diabetic Medicine (5 papers)Atherosclerosis (5 papers)Circulation (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David Preiss
102 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Endocrinology, Diabetes and Metabolism 4.4k
- Cardiology and Cardiovascular Medicine 2.1k
- Surgery 3.3k
- Nephrology 340
- Epidemiology 1.5k
Countries citing papers authored by David Preiss
This map shows the geographic impact of David Preiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Preiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Preiss more than expected).
Fields of papers citing papers by David Preiss
This network shows the impact of papers produced by David Preiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Preiss. The network helps show where David Preiss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Preiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease | 2017 | 2 |
| 4 | 2017 | 48 | |
| 5 | Long-term efficacy of evolocumab in reducing lipids in EU subjects with and without type 2 diabetes: an analysis from the open-label extension OSLER studies | 2016 | 1 |
| 6 | 2016 | 3 | |
| 7 | Evaluation of the one-year efficacy, safety and glycaemic effects of evolocumab (AMG 145) in 4,802 subjects with, at high risk for, or at low risk for, diabetes mellitus | 2015 | 6 |
| 8 | 2015 | 11 | |
| 9 | Efficacy and Safety of the PCSK9 Inhibitor Evolocumab (AMG 145) in Patients with Type 2 Diabetes | 2015 | 4 |
| 10 | The effect of metformin on circulating amino acids in the Carotid Atherosclerosis: Metformin for insulin Resistance (CAMERA) trial reveals a novel effect on four amino acids | 2015 | 1 |
| 11 | 2015 | 25 | |
| 12 | 2015 | 29 | |
| 13 | Efficacy of one year of treatment with the PCSK9 inhibitor evolocumab (AMG 145) in 4,802 subjects with or without type 2 diabetes | 2015 | 0 |
| 14 | 2014 | 37 | |
| 15 | 2014 | 3 | |
| 16 | 2012 | 55 | |
| 17 | 2012 | 41 | |
| 18 | 2011 | 63 | |
| 19 | 2010 | 11 | |
| 20 | 2007 | 0 |
About David Preiss
David Preiss is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Cardiology and Cardiovascular Medicine, Surgery and Cancer Research, having authored 106 papers that have together received 8.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (38 papers), Diabetes Treatment and Management (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Liver Disease Diagnosis and Treatment (12 papers), Cardiovascular Function and Risk Factors (10 papers), Diabetes Management and Research (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Surgery (3.3k citations), Nephrology (340 citations) and Epidemiology (1.5k citations). David Preiss has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Naveed Sattar, John J.V. McMurray, Søren Lund Kristensen, Pardeep S. Jhund, Mark C. Petrie, Lars Køber, Kausik K. Ray, Rasmus Rørth, Sreenivasa Rao Kondapally Seshasai and Kieran F. Docherty. Their work appears in journals such as The Lancet Diabetes & Endocrinology, Diabetologia, Diabetic Medicine, Atherosclerosis and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.